SlideShare a Scribd company logo
L6-Glucose-elevating agents
ALICE 2/28/2023
1
ALICE BCM 329.
Glucose-elevating agents
• Glucose-elevating agents raise blood level of
glucose when severe hypoglycemia occurs at <40
mg/dL.
• Two agents are used to elevate glucose:
diazoxide and glucagon.
2/28/2023
2
ALICE BCM 329.
Glucose-elevating agents
• Therapeutic Action
• Increasing blood glucose by decreasing insulin
release and accelerating the breakdown of
glycogen in the liver to release glucose.
2/28/2023
3
ALICE BCM 329.
Glucose-elevating agents
• Indications
• Diazoxide- Oral formulations are indicated for
the management of hypoglycemia; A potent
antipressor..intravenous use for management of
severe hypertension.
• Glucagon is used to counteract severe
hypoglycemic reactions.
2/28/2023
4
ALICE BCM 329.
Glucose-elevating agents
Dosing and administration
Oral and parenteral formulations are available
The dosage is usually individualized.
Review the dosage guidelines@
https://www.drugs.com/dosage/glucagen.html
https://www.drugs.com/dosage/proglycem.html
2/28/2023
5
ALICE BCM 329.
Glucose-elevating agents
• Pharmacokinetics for IV
ROUTE ONSET PEAK DURATION
IV 1min 15 min 9-20 min
T1/2: 3-10 min
Metabolism: liver
Excretion: bile,
urine
2/28/2023
6
ALICE BCM 329.
Glucose-elevating agents
• Contraindications and Cautions
• Diazoxide is contraindicated with known
allergies to sulfonamides or thiazides.
• Pregnancy and lactation. Associated with
adverse effects to fetus and baby.
2/28/2023
7
ALICE BCM 329.
Glucose-elevating agents
• Contraindications and Cautions
• There are no adequate studies on glucagon and
pregnancy, so use should be reserved for those
situations in which the benefits to the mother
outweigh any potential risks to the fetus.
• Caution should be used in patients with renal or
hepatic dysfunction or cardiovascular disease.
2/28/2023
8
ALICE BCM 329.
Glucose-elevating agents
• Adverse Effects
• Glucagon is associated with GI upset, nausea,
and vomiting.
• Diazoxide is associated with vascular effects,
including hypotension, headache, cerebral
ischemia, weakness, heart failure, and
arrhythmias.
• This is because diazoxide has the ability to relax
arteriolar smooth muscle.
2/28/2023
9
ALICE BCM 329.
Glucose-elevating agents
• Interactions
• Diazoxide with thiazide diuretics can increase
risk of toxicity because these two are structurally
the same.
• Glucagon with oral anticoagulants will increase
anticoagulation effects.
2/28/2023
10
ALICE BCM 329.
Glucose-elevating agents
• Vital interventions
• Monitor blood glucose levels to evaluate the
effectiveness of the drug.
• Have insulin on standby during emergency use
to treat severe hyperglycemia if it occurs as a
result of overdose.
• Monitor nutritional status
2/28/2023
11
ALICE BCM 329.
Glucose-elevating agents
• Monitor patients receiving diazoxide for
potential cardiovascular effects, including blood
pressure, heart rhythm and output, and weight
changes to avert serious adverse reactions.
• Provide comfort measures to help patient cope
with drug effects.
• Provide patient education about drug effects and
warning signs to report to enhance patient
knowledge and to promote compliance.
2/28/2023
12
ALICE BCM 329.
Glucose-elevating agents
• Monitor patient response to therapy
(stabilization of blood glucose levels).
• Monitor for adverse effects (hyperglycemia and
GI distress).
• Evaluate patient understanding on drug therapy
by asking patient to name the drug, its
indication, and adverse effects to watch for.
• Monitor patient compliance to drug therapy.
2/28/2023
13
ALICE BCM 329.

More Related Content

PDF
Presentation on Antidiabetic agents.pdf.
PPTX
New treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
PPT
Oral hypoglycaemic drugs
PPT
Diabetes mellitus amol
PPTX
EMPAGLIFLOZIN & DAPAGLIFLOZIN COMPARISON FOR DIABETIC TYPE 2
PPTX
COMPARISN of EMPAGLIFLOZIN & DAPAGLIFLOZIN FOR ANTIDIABETIC.pptx
PDF
240222 VU_NO-iNSULIN TREATMENT nnnnn.pdf
PPTX
Type2 dm
Presentation on Antidiabetic agents.pdf.
New treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
Oral hypoglycaemic drugs
Diabetes mellitus amol
EMPAGLIFLOZIN & DAPAGLIFLOZIN COMPARISON FOR DIABETIC TYPE 2
COMPARISN of EMPAGLIFLOZIN & DAPAGLIFLOZIN FOR ANTIDIABETIC.pptx
240222 VU_NO-iNSULIN TREATMENT nnnnn.pdf
Type2 dm

Similar to L6-Glucose Elevating agents.ppt (20)

PPTX
Diabetes
PPTX
Digoxin.pptx
PPTX
DIABETIC NEPHROPATHY-management.pptx recent
PPTX
newer peritinrsl fiakduduv solutions.pptx
PPT
DIABETES MELLITUS.ppt
PPTX
newer peritomewl dialysis solutions.pptx
PPTX
INSULIN.pptx
PPTX
Management of Diabetes Mellitus.pptx
PPTX
Anesthesia Management for Diabetic mellitus.2019,by Assefa Hika
PPTX
Diabetes mellitus
PDF
DM Medication.pdf
DOCX
Leaflet (Metformin) By Abhijit Gaikwad
PPTX
Antidiabetic agents
PPTX
FDA Approvals - December 2017
PPTX
TYPE 2 DIABETS MELLITUS, diagnosis and treatment.pptx
PPTX
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes, Moh'd sharshir
PPTX
INSULIN AND GLUCOSE LOWERING AGENTS.pptx
PPTX
Hypoglycemic agents
PDF
Antidiabetic drug-1
Diabetes
Digoxin.pptx
DIABETIC NEPHROPATHY-management.pptx recent
newer peritinrsl fiakduduv solutions.pptx
DIABETES MELLITUS.ppt
newer peritomewl dialysis solutions.pptx
INSULIN.pptx
Management of Diabetes Mellitus.pptx
Anesthesia Management for Diabetic mellitus.2019,by Assefa Hika
Diabetes mellitus
DM Medication.pdf
Leaflet (Metformin) By Abhijit Gaikwad
Antidiabetic agents
FDA Approvals - December 2017
TYPE 2 DIABETS MELLITUS, diagnosis and treatment.pptx
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes, Moh'd sharshir
INSULIN AND GLUCOSE LOWERING AGENTS.pptx
Hypoglycemic agents
Antidiabetic drug-1
Ad

More from StacyJuma1 (15)

PPT
urinary bladder conditions.ppt
PPT
VENTRICULAR SEPTAL DEFECT.ppt
PPT
L5-HYPOTHALAMIC AGENTS.ppt
PPTX
Orthopedic.pptx
PPTX
Disorders of the Liver.pptx
PPT
Compartment syndrome.ppt
PPT
FEBRILE CONVULSIONS.ppt
PPT
CONVULSIONS (SEIZURES).ppt
PPT
Nutritional Disorders.ppt
PPT
Growth and Development.ppt
PPT
L4-PHARMACOLOGY OF ANAESTHESIA.ppt
PPT
History_of_Social_Welfare_and_Social_Wor.ppt
PPT
1. Introduction to Orthopaedics.ppt
PPT
METABOLIC RESPONSE TO INJURY.ppt
PPT
1 Reproductive Anatomy.ppt
urinary bladder conditions.ppt
VENTRICULAR SEPTAL DEFECT.ppt
L5-HYPOTHALAMIC AGENTS.ppt
Orthopedic.pptx
Disorders of the Liver.pptx
Compartment syndrome.ppt
FEBRILE CONVULSIONS.ppt
CONVULSIONS (SEIZURES).ppt
Nutritional Disorders.ppt
Growth and Development.ppt
L4-PHARMACOLOGY OF ANAESTHESIA.ppt
History_of_Social_Welfare_and_Social_Wor.ppt
1. Introduction to Orthopaedics.ppt
METABOLIC RESPONSE TO INJURY.ppt
1 Reproductive Anatomy.ppt
Ad

Recently uploaded (20)

PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
Acute Coronary Syndrome for Cardiology Conference
PDF
Calcified coronary lesions management tips and tricks
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
Post Op complications in general surgery
PPTX
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PPT
Infections Member of Royal College of Physicians.ppt
PPTX
Manage HIV exposed child and a child with HIV infection.pptx
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PPTX
Neonate anatomy and physiology presentation
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
Vaccines and immunization including cold chain , Open vial policy.pptx
OSCE Series ( Questions & Answers ) - Set 6.pdf
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
Acute Coronary Syndrome for Cardiology Conference
Calcified coronary lesions management tips and tricks
Lecture 8- Cornea and Sclera .pdf 5tg year
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
OSCE Series Set 1 ( Questions & Answers ).pdf
PEADIATRICS NOTES.docx lecture notes for medical students
Electrolyte Disturbance in Paediatric - Nitthi.pptx
Post Op complications in general surgery
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
Infections Member of Royal College of Physicians.ppt
Manage HIV exposed child and a child with HIV infection.pptx
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
Neonate anatomy and physiology presentation
Copy of OB - Exam #2 Study Guide. pdf
nephrology MRCP - Member of Royal College of Physicians ppt

L6-Glucose Elevating agents.ppt

  • 2. Glucose-elevating agents • Glucose-elevating agents raise blood level of glucose when severe hypoglycemia occurs at <40 mg/dL. • Two agents are used to elevate glucose: diazoxide and glucagon. 2/28/2023 2 ALICE BCM 329.
  • 3. Glucose-elevating agents • Therapeutic Action • Increasing blood glucose by decreasing insulin release and accelerating the breakdown of glycogen in the liver to release glucose. 2/28/2023 3 ALICE BCM 329.
  • 4. Glucose-elevating agents • Indications • Diazoxide- Oral formulations are indicated for the management of hypoglycemia; A potent antipressor..intravenous use for management of severe hypertension. • Glucagon is used to counteract severe hypoglycemic reactions. 2/28/2023 4 ALICE BCM 329.
  • 5. Glucose-elevating agents Dosing and administration Oral and parenteral formulations are available The dosage is usually individualized. Review the dosage guidelines@ https://www.drugs.com/dosage/glucagen.html https://www.drugs.com/dosage/proglycem.html 2/28/2023 5 ALICE BCM 329.
  • 6. Glucose-elevating agents • Pharmacokinetics for IV ROUTE ONSET PEAK DURATION IV 1min 15 min 9-20 min T1/2: 3-10 min Metabolism: liver Excretion: bile, urine 2/28/2023 6 ALICE BCM 329.
  • 7. Glucose-elevating agents • Contraindications and Cautions • Diazoxide is contraindicated with known allergies to sulfonamides or thiazides. • Pregnancy and lactation. Associated with adverse effects to fetus and baby. 2/28/2023 7 ALICE BCM 329.
  • 8. Glucose-elevating agents • Contraindications and Cautions • There are no adequate studies on glucagon and pregnancy, so use should be reserved for those situations in which the benefits to the mother outweigh any potential risks to the fetus. • Caution should be used in patients with renal or hepatic dysfunction or cardiovascular disease. 2/28/2023 8 ALICE BCM 329.
  • 9. Glucose-elevating agents • Adverse Effects • Glucagon is associated with GI upset, nausea, and vomiting. • Diazoxide is associated with vascular effects, including hypotension, headache, cerebral ischemia, weakness, heart failure, and arrhythmias. • This is because diazoxide has the ability to relax arteriolar smooth muscle. 2/28/2023 9 ALICE BCM 329.
  • 10. Glucose-elevating agents • Interactions • Diazoxide with thiazide diuretics can increase risk of toxicity because these two are structurally the same. • Glucagon with oral anticoagulants will increase anticoagulation effects. 2/28/2023 10 ALICE BCM 329.
  • 11. Glucose-elevating agents • Vital interventions • Monitor blood glucose levels to evaluate the effectiveness of the drug. • Have insulin on standby during emergency use to treat severe hyperglycemia if it occurs as a result of overdose. • Monitor nutritional status 2/28/2023 11 ALICE BCM 329.
  • 12. Glucose-elevating agents • Monitor patients receiving diazoxide for potential cardiovascular effects, including blood pressure, heart rhythm and output, and weight changes to avert serious adverse reactions. • Provide comfort measures to help patient cope with drug effects. • Provide patient education about drug effects and warning signs to report to enhance patient knowledge and to promote compliance. 2/28/2023 12 ALICE BCM 329.
  • 13. Glucose-elevating agents • Monitor patient response to therapy (stabilization of blood glucose levels). • Monitor for adverse effects (hyperglycemia and GI distress). • Evaluate patient understanding on drug therapy by asking patient to name the drug, its indication, and adverse effects to watch for. • Monitor patient compliance to drug therapy. 2/28/2023 13 ALICE BCM 329.